Cargando…
Current Therapies and New Targets to Fight Melanoma: A Promising Role for the β3-Adrenoreceptor
Melanoma is one of the most aggressive types of cancer and the most deadly skin cancer. According to World Health Organization, about 132,000 melanoma skin cancers occur globally each year. Thanks to the efficacy of new therapies, life expectation has been improved over the last years. However, some...
Autores principales: | Filippi, Luca, Bruno, Gennaro, Domazetovic, Vladana, Favre, Claudio, Calvani, Maura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352170/ https://www.ncbi.nlm.nih.gov/pubmed/32486190 http://dx.doi.org/10.3390/cancers12061415 |
Ejemplares similares
-
Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
por: Calvani, Maura, et al.
Publicado: (2019) -
β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment
por: Calvani, Maura, et al.
Publicado: (2020) -
β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells
por: Calvani, Maura, et al.
Publicado: (2018) -
β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation
por: Pasha, Amada, et al.
Publicado: (2021) -
β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance
por: Calvani, Maura, et al.
Publicado: (2020)